Step-by-step guide from finding a trial to completing enrollment.
Enrolling in a clinical trial is a multi-step process that typically takes several weeks from initial interest to your first study visit. Each trial has its own specific inclusion criteria (what you need to have) and exclusion criteria (what would disqualify you). Understanding the process in advance helps you prepare and reduces surprises along the way.
One important thing to understand: enrollment is not a commitment you make all at once. You have the right to withdraw at any point during the process, including after you've signed the informed consent form. Federal regulations (specifically 45 CFR 46, the "Common Rule") protect your right to leave a trial at any time for any reason, without penalty to your ongoing medical care.
Start by searching trial registries, disease-specific advocacy organizations, or asking your specialist for referrals. Tools like Trial Friend translate eligibility criteria into plain language to help you quickly identify trials you may qualify for. You can also ask patient advocacy groups like NORD or disease-specific foundations, who often maintain curated lists of active trials.
Tip: Cast a wide net. Search by your specific diagnosis, by the type of treatment (gene therapy, enzyme replacement, small molecule, etc.), and by location. Many trials have sites in multiple cities.
Every listed trial includes contact information for the research coordinator or principal investigator's office. Call or email them. You do not need a referral from your doctor to make this initial inquiry, though having your medical records ready will help. Research coordinators receive patient inquiries regularly and can tell you quickly whether the trial is still enrolling and whether your situation is a general fit.
Tip: When you call, be ready to share: your diagnosis, when you were diagnosed, current medications, and any prior treatments. This helps the coordinator assess initial eligibility.
The research coordinator will conduct a preliminary assessment, usually by phone. They'll ask about your medical history, current health status, medications, and any previous trial participation. This step exists to save everyone time. If there's a clear exclusion criterion that applies to you (for example, a recent surgery or a conflicting medication), they'll let you know before you invest time in an in-person screening visit.
Tip: Ask the coordinator about the visit schedule, whether travel assistance is available, and what the time commitment looks like. Some trials require weekly visits; others only monthly.
If the pre-screen looks promising, you'll be invited for a formal screening visit at the trial site. This typically includes blood work, urine tests, physical examination, vital signs, electrocardiogram (ECG), medical history review, and potentially imaging studies. For certain conditions, you may need genetic testing, a tissue biopsy, or specialized assessments. The screening visit is at no cost to you. The results determine whether you meet all the protocol's eligibility criteria.
Tip: Screening visits can take several hours. Some trials require multiple screening visits over a period of days or weeks. Ask in advance so you can plan accordingly.
Before any study procedures can begin, you must provide informed consent. This is a formal process where the research team reviews a detailed consent document with you. The document covers the purpose of the study, what treatments or procedures are involved, known risks and potential benefits, alternative treatments available, how your privacy will be protected, and your right to withdraw at any time. You will have time to read the document, ask questions, discuss with family, and even take it home to review with your own doctor before signing.
Tip: Informed consent is not a contract. It does not waive any of your legal rights. If anything is unclear, ask for clarification. A good research team will welcome your questions.
Once enrolled, the research team will collect baseline data: your current disease status, biomarkers, quality-of-life measures, and other metrics that will be tracked throughout the study. If the trial is randomized, this is when you'll be assigned to a treatment group. You may or may not know which group you're in, depending on the blinding protocol. Your first dose or treatment session is typically scheduled shortly after baseline is completed.
Tip: Keep a personal log of your symptoms starting from baseline. This can help you communicate clearly with the research team throughout the study.
Every trial has two sets of criteria. Inclusion criteria describe what you need to have to participate: a confirmed diagnosis, a certain disease severity, age range, or specific biomarkers. Exclusion criteria describe what would prevent your participation: certain comorbidities, organ function thresholds, pregnancy, recent surgeries, specific prior treatments, or conflicting medications.
Criteria exist to protect participant safety and to produce reliable scientific results. A trial studying a liver disease treatment might exclude patients with severely compromised kidney function, because kidney issues could make it impossible to distinguish drug side effects from pre-existing problems. A trial might exclude patients who have already received a specific type of therapy because prior treatment could affect how they respond to the study drug.
Criteria can seem arbitrary or frustrating, especially when you're looking for treatment options. If you're excluded from one trial, don't stop looking. Different trials studying the same disease often have different eligibility requirements. A criterion that disqualifies you from one study might not apply to another.
Once you're enrolled, the research team will provide a detailed schedule of study visits, procedures, and assessments. The frequency varies significantly by trial. Some require weekly visits for infusion therapies; others may only need monthly check-ins or even remote monitoring between quarterly in-person visits.
At each visit, the research team will monitor your health, track disease progression or improvement, assess for side effects, and collect data according to the study protocol. You'll likely have regular blood draws, vital sign checks, and questionnaires about your symptoms and quality of life. Some trials include imaging studies, cognitive assessments, or functional tests depending on the condition being studied.
Many trials also provide a study nurse or coordinator who serves as your primary point of contact. This person can answer questions between visits, help manage side effects, and coordinate with your personal physicians if needed.
If you experience a side effect or adverse event, report it to the research team immediately. They have protocols for managing adverse events and can adjust your treatment or care accordingly. Serious adverse events are reported to the FDA, the Institutional Review Board (IRB), and the study sponsor, which helps maintain safety oversight for all participants.
Screening failure is common. Depending on the trial, anywhere from 20% to 50% of people who begin screening don't ultimately enroll. The reasons range from lab values being slightly out of range, to discovering a previously undiagnosed condition, to the trial reaching its enrollment cap before your screening is complete.
If you don't qualify, ask the research coordinator why. Understanding the specific reason can help you identify other trials where that criterion doesn't apply. Some criteria are related to timing (for example, requiring a washout period from a previous medication), and you may become eligible later.
Patient advocacy organizations and trial navigators can also help you find alternative studies. Many maintain databases of trials by condition and can point you toward options you may not have found on your own.